Last $78.84 USD
Change Today +0.34 / 0.43%
Volume 86.1K
USNA On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 6:40 PM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

usana health sciences inc (USNA) Snapshot

Open
$78.65
Previous Close
$78.50
Day High
$79.50
Day Low
$77.87
52 Week High
10/22/13 - $92.00
52 Week Low
04/23/13 - $49.46
Market Cap
1.1B
Average Volume 10 Days
166.6K
EPS TTM
$5.57
Shares Outstanding
13.9M
EX-Date
--
P/E TM
14.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for USANA HEALTH SCIENCES INC (USNA)

usana health sciences inc (USNA) Related Bloomberg News

View More Bloomberg News

usana health sciences inc (USNA) Related Businessweek News

No Related Businessweek News Found

usana health sciences inc (USNA) Details

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products focusing on chronic degenerative disease worldwide. It offers the USANA Nutritionals Essentials product line, which includes vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods comprising low-glycemic meal replacement shakes, snack bars, and other related products that provide optimal macro-nutrition. The company also provides Sensé—beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products designed specifically for prenatal, infant, and young child age groups in China. In addition, it offers materials and online tools, such as associate starter kit and product brochures that are designed to assist associates in building their businesses and in marketing products. USANA Health Sciences, Inc. primarily distributes its products through a network marketing system of independent distributors. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

1,480 Employees
Last Reported Date: 03/13/14
Founded in 1992

usana health sciences inc (USNA) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: $530.8K
Founder and Chairman
Total Annual Compensation: --
Chief Financial Officer and Principal Account...
Total Annual Compensation: $317.7K
President of the Americas, Europe & South Pac...
Total Annual Compensation: $583.5K
President of Asia & Greater China Operations
Total Annual Compensation: $575.1K
Compensation as of Fiscal Year 2013.

usana health sciences inc (USNA) Key Developments

USANA Health Sciences Inc. Presents at 26th Annual ROTH Conference, Mar-11-2014 04:00 PM

USANA Health Sciences Inc. Presents at 26th Annual ROTH Conference, Mar-11-2014 04:00 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States. Speakers: Paul A. Jones, Interim Chief Financial Officer and Principal Accounting Officer.

USANA Health Sciences Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 28, 2013; Provides Earnings Guidance for 2014

USANA Health Sciences Inc. has reported that net earnings for the fourth quarter ended December 28, 2013 were $20.28 million, or $1.41 per diluted share, compared to $18.45 million, or $1.27 per diluted share, for the same quarter ended December 29, 2012. Net sales for the fourth quarter ended December 28, 2013 were $186.27 million, compared to $168.53 million for the same quarter ended December 29, 2012. Net earnings for the year ended December 28, 2013 were $79.02 million, or $5.56 per diluted share, compared to $66.43 million, or $4.45 per diluted share, for the year ended December 29, 2012. Net sales for the year ended December 28, 2013 were $718.17 million, compared to $648.73 million for the year ended December 29, 2012. For 2014, the company expects consolidated net sales to be between $790 million and $810 million and earnings per share to be between $5.80 and $5.95.

USANA Health Sciences Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 28, 2013; Provides Earnings Guidance for the Full Year of 2014

USANA Health Sciences Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 28, 2013. For the fourth quarter of 2013, net sales increased by 10.5% to $186.3 million, compared with $168.5 million in the prior-year period. Net earnings for the fourth quarter increased to $20.3 million, a 9.9% improvement, compared with $18.45 million for the prior-year period. This increase was driven by higher net sales, lower relative selling, general and administrative expense, and a lower effective tax rate. The 29.8% effective tax rate for the fourth quarter was 470 basis points lower than the fourth quarter of 2012 due primarily to benefits from a Utah state tax policy election change recognized in the fourth quarter of 2013. Earnings per diluted share for the quarter increased by 11% to $1.41 compared with $1.27 in the fourth quarter of the prior year. The growth in earnings per share was attributable to higher net earnings. Earnings from operations were $28,082,000 against $29,004,000 for the same period of last year. Earnings before income taxes were $28,152,000 against $28,906,000 for the same period of last year. For the year ended December 28, 2013, net sales increased by 10.7% to $718.2 million, compared with $648.7 million in the prior year. Net earnings for 2013 were increased by 19.0% to $79.0 million, or $5.56 per diluted share, compared with $66.4 million or $4.45 per diluted share in the prior year. The increase in net earnings was due primarily to higher net sales and lower relative operating expenses. Cash generated from operations totaled $99.9 million for the year ended December 28, 2013. Earnings from operations were $98,179,000 against $116,712,000 for the same period of last year. Earnings before income taxes were $98,426,000 against $116,581,000 for the same period of last year. The company provided consolidated earnings guidance for the full year of 2014. For the period, the company expects net sales between $790 million and $810 million; earnings per share between $5.80 and $5.95; gross margins of 82.5%; operating margin of around 16%; and an effective tax rate of 34%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
USNA:US $78.84 USD +0.34

USNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Inter Parfums Inc $35.05 USD -0.09
Prestige Brands Holdings Inc $27.56 USD -0.33
Shaklee Global Group Inc ¥3,725 JPY -75.00
WD-40 Co $73.80 USD -0.38
View Industry Companies
 

Industry Analysis

USNA

Industry Average

Valuation USNA Industry Range
Price/Earnings 14.1x
Price/Sales 1.6x
Price/Book 4.2x
Price/Cash Flow 13.8x
TEV/Sales 1.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact USANA HEALTH SCIENCES INC, please visit www.usanahealthsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.